Investors
Corporate Profile
Elicio Therapeutics is a clinical-stage biotechnology company engineering investigational lymph node-targeted vaccines for an array of aggressive cancers and infectious diseases.
Press Releases
Events
May 13, 2024 - May 17, 2024
May 31, 2024